320 related articles for article (PubMed ID: 17981048)
1. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
[TBL] [Abstract][Full Text] [Related]
2. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
[TBL] [Abstract][Full Text] [Related]
3. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway.
Michaelson JS; Burkly LC
Results Probl Cell Differ; 2009; 49():145-60. PubMed ID: 19513634
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa).
Shui Y; Guan ZB; Zhang SQ
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982
[TBL] [Abstract][Full Text] [Related]
6. Considering TWEAK as a target for therapy in renal and vascular injury.
Ortiz A; Sanz AB; Muñoz García B; Moreno JA; Sánchez Niño MD; Martín-Ventura JL; Egido J; Blanco-Colio LM
Cytokine Growth Factor Rev; 2009 Jun; 20(3):251-8. PubMed ID: 19482507
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases.
Yepes M; Winkles JA
Drug News Perspect; 2006 Dec; 19(10):589-95. PubMed ID: 17299600
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J
Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609
[TBL] [Abstract][Full Text] [Related]
10. TWEAK induces liver progenitor cell proliferation.
Jakubowski A; Ambrose C; Parr M; Lincecum JM; Wang MZ; Zheng TS; Browning B; Michaelson JS; Baetscher M; Wang B; Bissell DM; Burkly LC
J Clin Invest; 2005 Sep; 115(9):2330-40. PubMed ID: 16110324
[TBL] [Abstract][Full Text] [Related]
11. TWEAK and Fn14: new molecular targets for cancer therapy?
Winkles JA; Tran NL; Berens ME
Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
[TBL] [Abstract][Full Text] [Related]
12. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
13. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
Kamijo S; Nakajima A; Kamata K; Kurosawa H; Yagita H; Okumura K
Rheumatology (Oxford); 2008 Apr; 47(4):442-50. PubMed ID: 18310134
[TBL] [Abstract][Full Text] [Related]
14. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
[TBL] [Abstract][Full Text] [Related]
15. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.
Xu H; Okamoto A; Ichikawa J; Ando T; Tasaka K; Masuyama K; Ogawa H; Yagita H; Okumura K; Nakao A
Biochem Biophys Res Commun; 2004 May; 318(2):422-7. PubMed ID: 15120617
[TBL] [Abstract][Full Text] [Related]
16. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.
Wang D; Fung JN; Tuo Y; Hu L; Chen C
Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.
Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR
J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112
[TBL] [Abstract][Full Text] [Related]
18. Fn14-Fc fusion protein regulates atherosclerosis in ApoE-/- mice and inhibits macrophage lipid uptake in vitro.
Schapira K; Burkly LC; Zheng TS; Wu P; Groeneweg M; Rousch M; Kockx MM; Daemen MJ; Heeneman S
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2021-7. PubMed ID: 19762780
[TBL] [Abstract][Full Text] [Related]
19. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells.
Tirnitz-Parker JE; Viebahn CS; Jakubowski A; Klopcic BR; Olynyk JK; Yeoh GC; Knight B
Hepatology; 2010 Jul; 52(1):291-302. PubMed ID: 20578156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]